View Financial HealthHydrix 配当と自社株買い配当金 基準チェック /06Hydrix配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesBoard Change • May 20Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • May 19Hydrix Limited has filed a Follow-on Equity Offering in the amount of AUD 8.183065 million.Hydrix Limited has filed a Follow-on Equity Offering in the amount of AUD 8.183065 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,636,613,082 Price\Range: AUD 0.005 Discount Per Security: AUD 0.0003 Security Features: Attached Options Transaction Features: Rights OfferingBoard Change • Dec 31Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Sep 30Hydrix Limited, Annual General Meeting, Nov 27, 2025Hydrix Limited, Annual General Meeting, Nov 27, 2025.Reported Earnings • Aug 31Full year 2025 earnings released: AU$0.011 loss per share (vs AU$0.038 loss in FY 2024)Full year 2025 results: AU$0.011 loss per share (improved from AU$0.038 loss in FY 2024). Revenue: AU$10.3m (down 3.4% from FY 2024). Net loss: AU$2.92m (loss narrowed 70% from FY 2024). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.Board Change • Aug 18Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 3 highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Board Change • Feb 04Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Oct 06Full year 2024 earnings released: AU$0.038 loss per share (vs AU$0.002 loss in FY 2023)Full year 2024 results: AU$0.038 loss per share (further deteriorated from AU$0.002 loss in FY 2023). Revenue: AU$10.6m (down 19% from FY 2023). Net loss: AU$9.56m (loss widened AU$9.16m from FY 2023). Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has fallen by 56% per year, which means it is significantly lagging earnings.お知らせ • Sep 19Hydrix Limited, Annual General Meeting, Nov 25, 2024Hydrix Limited, Annual General Meeting, Nov 25, 2024.New Risk • Sep 06New major risk - Negative shareholders equityThe company has negative equity. Total equity: -AU$3.4m This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$1.9m free cash flow). Shares are highly illiquid. Negative equity (-AU$3.4m). Earnings have declined by 1.3% per year over the past 5 years. Market cap is less than US$10m (AU$2.80m market cap, or US$1.88m).Board Change • Nov 03Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 5 non-independent directors. Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Oct 17Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 5 non-independent directors. Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Sep 29Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 5 non-independent directors. Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Sep 20Hydrix Limited, Annual General Meeting, Nov 13, 2023Hydrix Limited, Annual General Meeting, Nov 13, 2023, at 11:01 AUS Eastern Standard Time.Board Change • Sep 06Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 5 non-independent directors. Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.New Risk • Aug 05New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$4.1m free cash flow). Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 8.2% per year over the past 5 years. Market cap is less than US$10m (AU$9.66m market cap, or US$6.34m). Minor Risk Shareholders have been diluted in the past year (29% increase in shares outstanding).Reported Earnings • Mar 03First half 2023 earnings released: AU$0.009 loss per share (vs AU$0.015 loss in 1H 2022)First half 2023 results: AU$0.009 loss per share (improved from AU$0.015 loss in 1H 2022). Revenue: AU$7.23m (up 40% from 1H 2022). Net loss: AU$1.96m (loss narrowed 18% from 1H 2022). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 36% per year, which means it is significantly lagging earnings.お知らせ • Feb 15Hydrix Limited Announces TGA Response to Guardian ApplicationHydrix Limited has been advised by the TGA that its current application for regulatory approval to market and distribute the Angel Medical Systems Guardian in Australia is not going to be accepted. Hydrix has not yet received formal notice of its decision from the TGA. Hydrix and AngelMed's position on the Guardian: Australia is one of eight countries where Hydrix has exclusive rights to distribute the Guardian covering a total population of more than 500 million people. Hydrix has commenced commercialisation of the Guardian in approved markets, including in Singapore and Malaysia, where eight successful implants have been completed. The TGA granted Hydrix until close of business the 27th of February 2023 to consider its response. Hydrix is seeking clarification from the TGA, and during this period, will consider the matters raised and evaluate the alternate pathways and options available to seek a TGA approval. The TGA has advised that in their view, AngelMed's clinical evidence did not demonstrate that the patient benefits sufficiently outweighed the risks of an implanted device using a pacemaker lead to monitor the heart signal to detect and alarm a patient of a life threatening situation. Hydrix and AngelMed are confident in the safety and efficacy of the Guardian device, and that the benefits outweigh the risks to improve the current standard of care based on more than 3,450 patient years of safety data and 1,550 patient years of efficacy /performance data. When the US FDA approved the device, it stated in its decision that the benefits outweigh the risks, and that the device "fills an unmet medical need by providing more effective diagnosis of a life-threatening condition compared to relying on patient symptoms alone." Hydrix confirms the TGA application and information variously provided included all of the information used to gain regulatory approval in the USA (June 2021), Singapore (August 2022) and Malaysia (June 2022) where it is now being prescribed to suitable ACS patients.Board Change • Jan 03Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 5 non-independent directors. Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Sep 15Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 31Full year 2022 earnings released: AU$0.032 loss per share (vs AU$0.068 loss in FY 2021)Full year 2022 results: AU$0.032 loss per share (up from AU$0.068 loss in FY 2021). Revenue: AU$10.5m (up 13% from FY 2021). Net loss: AU$5.55m (loss narrowed 43% from FY 2021). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.Board Change • Aug 11Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 03First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: AU$0.015 loss per share (up from AU$0.039 loss in 1H 2021). Revenue: AU$5.17m (up 1.5% from 1H 2021). Net loss: AU$2.40m (loss narrowed 50% from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.Reported Earnings • Sep 02Full year 2021 earnings released: AU$0.068 loss per share (vs AU$0.043 loss in FY 2020)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: AU$9.31m (down 41% from FY 2020). Net loss: AU$9.78m (loss widened 204% from FY 2020). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.Is New 90 Day High Low • Feb 27New 90-day low: AU$0.23The company is down 20% from its price of AU$0.28 on 27 November 2020. The Australian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 28% over the same period.Is New 90 Day High Low • Dec 14New 90-day low: AU$0.27The company is down 25% from its price of AU$0.35 on 16 September 2020. The Australian market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 9.0% over the same period.決済の安定と成長配当データの取得安定した配当: HYDの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: HYDの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Hydrix 配当利回り対市場HYD 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (HYD)n/a市場下位25% (AU)2.8%市場トップ25% (AU)6.8%業界平均 (Electronic)1.1%アナリスト予想 (HYD) (最長3年)n/a注目すべき配当: HYDは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: HYDは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: HYDの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: HYDが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YAU 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 18:07終値2026/05/22 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Hydrix Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Stuart RobertsPitt Street Research Pty Ltd.
Board Change • May 20Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • May 19Hydrix Limited has filed a Follow-on Equity Offering in the amount of AUD 8.183065 million.Hydrix Limited has filed a Follow-on Equity Offering in the amount of AUD 8.183065 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,636,613,082 Price\Range: AUD 0.005 Discount Per Security: AUD 0.0003 Security Features: Attached Options Transaction Features: Rights Offering
Board Change • Dec 31Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Sep 30Hydrix Limited, Annual General Meeting, Nov 27, 2025Hydrix Limited, Annual General Meeting, Nov 27, 2025.
Reported Earnings • Aug 31Full year 2025 earnings released: AU$0.011 loss per share (vs AU$0.038 loss in FY 2024)Full year 2025 results: AU$0.011 loss per share (improved from AU$0.038 loss in FY 2024). Revenue: AU$10.3m (down 3.4% from FY 2024). Net loss: AU$2.92m (loss narrowed 70% from FY 2024). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.
Board Change • Aug 18Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 3 highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Board Change • Feb 04Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Oct 06Full year 2024 earnings released: AU$0.038 loss per share (vs AU$0.002 loss in FY 2023)Full year 2024 results: AU$0.038 loss per share (further deteriorated from AU$0.002 loss in FY 2023). Revenue: AU$10.6m (down 19% from FY 2023). Net loss: AU$9.56m (loss widened AU$9.16m from FY 2023). Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has fallen by 56% per year, which means it is significantly lagging earnings.
お知らせ • Sep 19Hydrix Limited, Annual General Meeting, Nov 25, 2024Hydrix Limited, Annual General Meeting, Nov 25, 2024.
New Risk • Sep 06New major risk - Negative shareholders equityThe company has negative equity. Total equity: -AU$3.4m This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$1.9m free cash flow). Shares are highly illiquid. Negative equity (-AU$3.4m). Earnings have declined by 1.3% per year over the past 5 years. Market cap is less than US$10m (AU$2.80m market cap, or US$1.88m).
Board Change • Nov 03Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 5 non-independent directors. Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Oct 17Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 5 non-independent directors. Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Sep 29Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 5 non-independent directors. Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Sep 20Hydrix Limited, Annual General Meeting, Nov 13, 2023Hydrix Limited, Annual General Meeting, Nov 13, 2023, at 11:01 AUS Eastern Standard Time.
Board Change • Sep 06Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 5 non-independent directors. Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
New Risk • Aug 05New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$4.1m free cash flow). Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 8.2% per year over the past 5 years. Market cap is less than US$10m (AU$9.66m market cap, or US$6.34m). Minor Risk Shareholders have been diluted in the past year (29% increase in shares outstanding).
Reported Earnings • Mar 03First half 2023 earnings released: AU$0.009 loss per share (vs AU$0.015 loss in 1H 2022)First half 2023 results: AU$0.009 loss per share (improved from AU$0.015 loss in 1H 2022). Revenue: AU$7.23m (up 40% from 1H 2022). Net loss: AU$1.96m (loss narrowed 18% from 1H 2022). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 36% per year, which means it is significantly lagging earnings.
お知らせ • Feb 15Hydrix Limited Announces TGA Response to Guardian ApplicationHydrix Limited has been advised by the TGA that its current application for regulatory approval to market and distribute the Angel Medical Systems Guardian in Australia is not going to be accepted. Hydrix has not yet received formal notice of its decision from the TGA. Hydrix and AngelMed's position on the Guardian: Australia is one of eight countries where Hydrix has exclusive rights to distribute the Guardian covering a total population of more than 500 million people. Hydrix has commenced commercialisation of the Guardian in approved markets, including in Singapore and Malaysia, where eight successful implants have been completed. The TGA granted Hydrix until close of business the 27th of February 2023 to consider its response. Hydrix is seeking clarification from the TGA, and during this period, will consider the matters raised and evaluate the alternate pathways and options available to seek a TGA approval. The TGA has advised that in their view, AngelMed's clinical evidence did not demonstrate that the patient benefits sufficiently outweighed the risks of an implanted device using a pacemaker lead to monitor the heart signal to detect and alarm a patient of a life threatening situation. Hydrix and AngelMed are confident in the safety and efficacy of the Guardian device, and that the benefits outweigh the risks to improve the current standard of care based on more than 3,450 patient years of safety data and 1,550 patient years of efficacy /performance data. When the US FDA approved the device, it stated in its decision that the benefits outweigh the risks, and that the device "fills an unmet medical need by providing more effective diagnosis of a life-threatening condition compared to relying on patient symptoms alone." Hydrix confirms the TGA application and information variously provided included all of the information used to gain regulatory approval in the USA (June 2021), Singapore (August 2022) and Malaysia (June 2022) where it is now being prescribed to suitable ACS patients.
Board Change • Jan 03Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 5 non-independent directors. Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Sep 15Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 31Full year 2022 earnings released: AU$0.032 loss per share (vs AU$0.068 loss in FY 2021)Full year 2022 results: AU$0.032 loss per share (up from AU$0.068 loss in FY 2021). Revenue: AU$10.5m (up 13% from FY 2021). Net loss: AU$5.55m (loss narrowed 43% from FY 2021). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.
Board Change • Aug 11Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Paul Wright was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 03First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: AU$0.015 loss per share (up from AU$0.039 loss in 1H 2021). Revenue: AU$5.17m (up 1.5% from 1H 2021). Net loss: AU$2.40m (loss narrowed 50% from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.
Reported Earnings • Sep 02Full year 2021 earnings released: AU$0.068 loss per share (vs AU$0.043 loss in FY 2020)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: AU$9.31m (down 41% from FY 2020). Net loss: AU$9.78m (loss widened 204% from FY 2020). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.
Is New 90 Day High Low • Feb 27New 90-day low: AU$0.23The company is down 20% from its price of AU$0.28 on 27 November 2020. The Australian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 28% over the same period.
Is New 90 Day High Low • Dec 14New 90-day low: AU$0.27The company is down 25% from its price of AU$0.35 on 16 September 2020. The Australian market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 9.0% over the same period.